Morphogenesis, Inc. announced that it expects to receive $15 million in funding from CohBar, Inc.

Morphogenesis, Inc. entered into a stock purchase agreement for the gross proceeds of $15 million on May 23, 2023. The transaction included participation from returning investor CohBar, Inc.